Squarepoint Ops LLC bought a new stake in Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,986 shares of the company's stock, valued at approximately $285,000. Squarepoint Ops LLC owned about 0.17% of Nutex Health as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the business. Bank of America Corp DE lifted its stake in shares of Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Nutex Health by 12.6% during the 4th quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock valued at $1,082,000 after buying an additional 3,826 shares in the last quarter. Northern Trust Corp purchased a new stake in shares of Nutex Health during the 4th quarter valued at approximately $200,000. Truist Financial Corp lifted its stake in shares of Nutex Health by 22.2% during the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company's stock valued at $1,127,000 after buying an additional 6,454 shares in the last quarter. Finally, Legato Capital Management LLC lifted its stake in shares of Nutex Health by 26.8% during the 4th quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock valued at $1,004,000 after buying an additional 6,697 shares in the last quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages recently commented on NUTX. Maxim Group upped their price target on shares of Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th. Benchmark increased their target price on shares of Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research note on Thursday, May 15th. Finally, Wall Street Zen cut shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd.
Read Our Latest Report on NUTX
Insider Activity
In other Nutex Health news, CFO Jon Christian Bates bought 1,000 shares of the firm's stock in a transaction that occurred on Tuesday, April 8th. The shares were bought at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the transaction, the chief financial officer now directly owns 4,888 shares in the company, valued at $399,887.28. This trade represents a 25.72% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 38.52% of the company's stock.
Nutex Health Price Performance
Shares of Nutex Health stock traded down $0.49 on Tuesday, hitting $117.17. 231,689 shares of the company traded hands, compared to its average volume of 74,876. The firm's 50-day simple moving average is $134.40 and its 200 day simple moving average is $76.08. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. The company has a market cap of $650.88 million, a P/E ratio of -12.48 and a beta of 0.04. Nutex Health Inc. has a 12-month low of $4.16 and a 12-month high of $184.28.
Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, beating the consensus estimate of ($0.15) by $2.71. The firm had revenue of $211.79 million for the quarter, compared to analysts' expectations of $81.09 million. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.
Nutex Health Profile
(
Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Stories
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
